Response by Sperber et al to Letter Regarding Article, "Serum Anti-NMDA (N-Methyl-D-Aspartate)-Receptor Antibodies and Long-Term Clinical Outcome After Stroke (PROSCIS-B)"

Stroke. 2020 Feb;51(2):e29. doi: 10.1161/STROKEAHA.119.028095. Epub 2020 Jan 13.

Authors

Pia S Sperber¹, Harald Prüss², Bob Siegerink³, Thomas G Liman¹

Affiliations

¹ Center for Stroke Research Berlin (CSB), Chariteé - Universitätsmedizin Berlin, Berlin, Germany.
² Klinik und Hochschulambulanz fuür Neurologie, Chariteé - Universitätsmedizin Berlin, Berlin, Germany.
³ Center for Stroke Research Berlin (CSB), Chariteé - Universitätsmedizin Berlin, Berlin, Germany, Chariteé - Universitätsmedizin Berlin, Berlin, Germany.

PMID: 31928150
DOI: 10.1161/STROKEAHA.119.028095

No abstract available

Publication types

Letter
Comment

MeSH terms

Autoantibodies
Humans
N-Methylaspartate*
Stroke*

Substances

Autoantibodies
N-Methylaspartate